d regulations are enabling data to flow more freely between silos and stakeholders. On the regulatory front, the past two years h=ve seen a shift in the US Food and Drug Administration's stance toward eval=ating and approving digital health tools, with the new regulatory framework=proposed in January 2019 more open to digital innova